ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2015

Mar 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2015-03-04

Reporting Person: GIVEN DOUGLAS B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-04	Common Stock	A	35000	—	Acquired	55000	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest on the one year anniversary of the date of grant.